Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human coagulation factor VIII in hemophilia A
CTR20150275Phase 3Completed
- Sponsor
- Danxia Biological Pharmaceutical
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antihemophilic factor human in hemophilia A, acquired haemophilia (AH), sponsored by Danxia Biological Pharmaceutical. Started Aug 2016; status: completed.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia Aacquired haemophilia (AH)
Beyond the preview
Go deeper on CTR20150275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150275.